Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becotatug Vedotin + Pucotenlimab + Cisplatin in Locally Advanced EGFR-Positive HNSCC
NCT07814287Phase 2Recruiting
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of becotatug vedotin, pucotenlimab in head and neck squamous cell carcinoma (HNSCC). Started Apr 2026; status: recruiting.
02
Drugs
becotatug vedotinpucotenlimab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07814287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07814287.